MarkMZalupskiMD

Clinical Trials

• S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors Start of enrollment: 2000 Apr 01

  Completed

  Phase 2

• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site Start of enrollment: 2001 May 01

  Terminated

  Phase 2

• Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer Start of enrollment: 2001 Dec 01

  Terminated

  Not Applicable

• Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine Start of enrollment: 2000 Mar 01

  Terminated

  Phase 2

• Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma Start of enrollment: 2001 Feb 01

  Completed

  Phase 2

• Radiation Therapy With Capecitabine in Rectal Cancer Start of enrollment: 2000 Oct 01

  Terminated

  Phase 2

• Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer Start of enrollment: 2003 Mar 01

  Completed

  Phase 2

• Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer Start of enrollment: 2003 Jun 01

  Completed

  Phase 2

• Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer Start of enrollment: 2004 Jun 01

  Completed

  Phase 1, Phase 2

• Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma Start of enrollment: 2004 Feb 01

  Completed

  Phase 1

• Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer Start of enrollment: 2007 Apr 01

  Completed

  Phase 2

• Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer Start of enrollment: 2006 Jun 01

  Completed

  Phase 1, Phase 2

• Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer Start of enrollment: 2010 Jun 01

  Completed

  Phase 2

• Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Start of enrollment: 2011 Dec 12

  Completed

  Phase 1, Phase 2

• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01

  Completed

  Phase 2

• Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2012 May 15

  Active, not recruiting

  Phase 2

• A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2012 Oct 01

  Completed

  Phase 1, Phase 2

• A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients Start of enrollment: 2011 Jun 01

  Completed

  Phase 2

• A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers Start of enrollment: 2011 Jul 01

  Completed

  Phase 2

• A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer Start of enrollment: 2012 Jul 01

  Completed

  Phase 1

• PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14

  Completed

  Phase 2

• S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01

  Terminated

  Phase 3

• Join now to see all